CommercialAdministrativeLow impact
Penicillamine
Blue Cross & Blue Shield of Mississippi·MS · Rheumatology, Gastroenterology, Internal Medicine·Medical Policy
Effective date
Mar 20, 2025
We identified it
Jun 20, 2026
Summary
Blue Cross Blue Shield Mississippi updated their penicillamine (Cuprimine/Depen) medical policy with minor language revisions, changing 'member' to 'individual' throughout the policy and clarifying that drug samples don't satisfy medical policy requirements. The core coverage criteria and prior authorization requirements remain unchanged.
Action Required
No immediate action required. This is a minor policy language update that doesn't change billing procedures or prior authorization requirements for penicillamine prescriptions. Continue following existing protocols for Wilson's disease, cystinuria, and rheumatoid arthritis patients requiring penicillamine.